Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis

    • Coronavirus disease (COVID-19)

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Scientific Resources
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Preventing Stroke: Uneven Progress

Preventing Stroke: Uneven Progress
OUR PURPOSE/ Preventing Stroke: Uneven Progress
September 21, 2017

Preventing Stroke: Uneven Progress – Economist Intelligence Unit Report Highlights Gaps in Screening and Diagnosis of Stroke Risk Factors

Today, stroke remains the second leading cause of death, although many cases are preventable.

The Economist Intelligence Unit (EIU) “Preventing Stroke: Uneven Progress,” report –sponsored by The Bristol-Myers Squibb-Pfizer Alliance – includes an analysis of the progress made by 20 countries in implementing stroke prevention policies. One finding was that efforts to screen people for stroke risk factors, including A Fiband hypertension, remain low, even in countries with established health care and developed economies. For example, on average, more than 75 percent of people aged 65 and older are not being screened for AFib during routine primary care examinations, even though this population is at high risk for stroke. Additionally, the report highlighted a disconnect between established best practices and everyday clinical practice, including gaps in the training of health care professionals to properly identify and treat stroke risks.

Stroke is an enormous burden and costs more than US $80 billion each year in the United States and Europe, including both healthcare costs and other expenses such as lost productivity.1,2 Data amassed from population studies in different countries tell us that as many as about one of every four people who suffers an ischemic stroke – the most common kind – had underlying AFib that went undiagnosed.3 Additionally, in more than one-quarter of patients with no history of cardiovascular disease, stroke is the first clinical manifestation of AFib.3 Modest improvements in diagnosis and treatment of stroke risk factors could save billions of dollars and help prevent many deaths.1

The Bristol-Myers Squibb-Pfizer Alliance has committed to investing in initiatives that drive insights, education, awareness and action to improve screening of stroke risk factors and reduce the incidence of stroke. It is working to drive better understanding of the barriers to earlier detection and identify potential strategies to address these through a multifaceted approach that includes support of investigator-initiated studies, investment in innovative commercial pilots, and support of advocacy and payer initiatives throughout the world.

One of these barriers is the absence of clear screening protocols and guidance on when and how to assess a patient for AFib, which remains an obstacle to early diagnosis and treatment. Existing data shows that opportunistic screening (screening conducted when a patient consults a healthcare professional for another purpose) for AF not showing any symptoms is cost-effective.4 Medical guidelines, including from the European Society of Cardiology, are beginning to recommend screening for AF in patients over the age of 65.5

However, to implement broader screening approaches (systematic screening) at the clinic level, the results of large, randomized controlled screening studies will be important to demonstrate cost-effectiveness, identify which populations may benefit the most, and inform guidelines and policy development. There is emerging evidence in support of systematic screening, including through the 27,000-patient StrokeSTOP trial in Sweden expected to report out data in 2019.5

Among other things, the “Preventing Stroke: Uneven Progress,” report concluded that future policies to prevent stroke should focus on integrated strategies to improve education around risk factors and implement opportunistic and/or systematic screenings to detect risk factors. By improving screening and early diagnosis, The Bristol-Myers Squibb-Pfizer Alliance –in collaboration with other key partners–can potentially help prevent strokes and related deaths.

1https://www.cdc.gov/stroke/facts.htm
2Wolfe DA, et al. The Burden of Stroke in Europe Report. King’s College London for the Stroke Alliance for Europe (SAFE).
3Freedman, B et.al. Stroke prevention in atrial fibrillation. Lancet 2016; 388: 806–17.
4Fitzmaurice et al. BMJ.2007;335:383
5Svennberg E et al. Circulation. 2015;131:2176-2184.

Click here to view the full "Preventing Stroke: Uneven Progress” report.

Related Hot Topics
WDAD_Hero_Image_380x300.jpg
World Duchenne Awareness Day: It’s More Than Muscles
Media Name: 3d_heart_chamber300x170.jpg
The Value of AFib Screening: Bridging the Gap Between the Undiagnosed and Early…
Media Name: Meet-JoAnne-Tile_300x170.jpg
Meet JoAnne, Helped by Pfizer RxPathways
Media Name: Unlocking-Value-of-Biologics-300x170px.jpg
Unlocking the Value of Biosimilars to Broaden The War Against Disease
Media Name: GHF Tory Vietnam 101_Tile 300x170px.jpg
GHF Tory: Vietnam 101
Media Name: GHF Tory Discovering My New Home_Tile 300x170px.jpg
GHF Tory: Discovering My New Home
ARMMAN Microsite Thumbnail
ARMMAN: Creating a New Path Forward
Bringing Business Expertise to Mumbai
Bringing Business Expertise to Mumbai
Tags
Brain & Nervous System
Health
Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.